L-securinine inhibits the proliferation of A549 lung cancer cells and promotes DKK1 promoter methylation

被引:17
作者
Han, Shuwen [1 ]
Yang, Xi [2 ,4 ]
Pan, Yuefen [1 ]
Qi, Quan [1 ]
Shen, Junjun [1 ]
Fang, Huifen [1 ]
Ji, Zhaoning [3 ]
机构
[1] Huzhou Cent Hosp, Dept Med Oncol, Huzhou 313000, Zhejiang, Peoples R China
[2] Wannan Med Coll, Dept Oncol, Wuhu, Anhui 241000, Peoples R China
[3] Wannan Med Coll, Yijishan Hosp, Canc Ctr, 2 Zheshan West Rd, Wuhu 241001, Anhui, Peoples R China
[4] Huzhou Cent Hosp, Dept Intervent Radiotherapy, Huzhou 313000, Zheijiang, Peoples R China
基金
中国国家自然科学基金;
关键词
L-securinine; lung cancer; DKK1; methylation; DNA METHYLATION; EXPRESSION; PCR; APOPTOSIS; OXIDATION; CATENIN;
D O I
10.3892/ol.2017.6693
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
L-securinine is a natural product extracted and isolated from the leaf of dried Securinega suffruticosa. The aim of the present study was to explore the effects of Lsecurinine on proliferation, and the methylation profile of the dickkopf-related protein 1 (DKK1) gene in human lung cancer cells and fibroblasts. L-securinine was extracted, isolated and the structure was identified. The cytotoxicity of L-securinine in A549 cells was evaluated by Cell Counting Kit-8 assays. The expression and DNA methylation profile of DKK genes was analyzed by reverse transcription-quantitative polymerase chain reaction and bisulfite sequencing polymerase chain reaction, respectively. L-securinine inhibited the proliferation of lung cancer cells; the half-maximal inhibitory concentration values were 8.92, 4.73 and 3.81 mu g/ml, at 24, 36 and 48 h post-treatment, respectively. DKK1, 2 and 3 expression was significantly increased in A549 cells compared with HLF-a cells. L-securinine induced the downregulation of DKK1 in A549 cells in a dose-dependent manner and induced methylation changes at CpG sites in the DKK1 promoter region. L-securinine may be a potential anticancer drug that mediates its effects by altering DKK1 gene methylation.
引用
收藏
页码:4243 / 4248
页数:6
相关论文
共 37 条
[1]  
Abdel-Magid AF, 2014, ACS MED CHEM LETT, V5, P456, DOI [10.1021/ml5000838, 10.1021/ml500276a]
[2]  
[Anonymous], 1983, Zhonghua Nei Ke Za Zhi, V22, P764
[3]  
[Anonymous], 2017, J LIGHTWAVE TECHNOL
[4]   The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers [J].
Atherly, A. J. ;
Camidge, D. R. .
BRITISH JOURNAL OF CANCER, 2012, 106 (06) :1100-1106
[5]   SECURININE ALKALOIDS - A NEW CLASS OF GABA RECEPTOR ANTAGONIST [J].
BEUTLER, JA ;
KARBON, EW ;
BRUBAKER, AN ;
MALIK, R ;
CURTIS, DR ;
ENNA, SJ .
BRAIN RESEARCH, 1985, 330 (01) :135-140
[6]  
Carcereny Enric, 2015, Transl Respir Med, V3, P1, DOI 10.1186/s40247-015-0013-z
[7]  
Carless MA, 2015, METHODS MOL BIOL, V1288, P193, DOI 10.1007/978-1-4939-2474-5_11
[8]   Effects of deranged metabolism on epigenetic changes in cancer [J].
Chandra, Vishal ;
Hong, Kyeong-Man .
ARCHIVES OF PHARMACAL RESEARCH, 2015, 38 (03) :321-337
[9]   PD-L1 expression is associated with advanced non-small cell lung cancer [J].
Chen, Zhiquan ;
Mei, Jiandong ;
Liu, Lunxu ;
Wang, Guochen ;
Li, Zuosheng ;
Hou, Jingpu ;
Zhang, Qiuyang ;
You, Zongbing ;
Zhang, Liu .
ONCOLOGY LETTERS, 2016, 12 (02) :921-927
[10]   Chiroptical study and absolute configuration of securinine oxidation products [J].
Chirkin, Egor ;
Atkatlian, William ;
Do, Quyen ;
Gaslonde, Thomas ;
Dufat, Thi-Hanh ;
Michel, Sylvie ;
Lemoine, Pascale ;
Genta-Jouve, Gregory ;
Poree, Francois-Hugues .
NATURAL PRODUCT RESEARCH, 2015, 29 (13) :1235-1242